Avalo Therapeutics (AVTX) Gross Margin Growth (3y) (2020 - 2024)
Avalo Therapeutics (AVTX) Gross Margin Growth (3y) (2020 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -230.00 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -168.00 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 193,280.00 |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 589.00 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 6.06 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 53.00 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 569.00 |
| 10 | Avalo Therapeutics | 854.16 Mn | 453.89 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | -21,949.00 |
| Dec 31, 2023 | 4,398.00 |
| Sep 30, 2023 | -9,773.00 |
| Jun 30, 2023 | -10,428.00 |
| Mar 31, 2023 | -11,360.00 |
| Dec 31, 2022 | -4,300.00 |
| Sep 30, 2022 | 248.00 |
| Jun 30, 2022 | -4,479.00 |
| Mar 31, 2022 | -3,217.00 |
| Dec 31, 2021 | -15,976.00 |
| Sep 30, 2021 | 909.00 |
| Jun 30, 2021 | 2,726.00 |
| Mar 31, 2021 | 299.00 |
| Dec 31, 2020 | 2,799.00 |
| Sep 30, 2020 | -693.00 |
| Jun 30, 2020 | -583.00 |
| Mar 31, 2020 | -240.00 |